![Robin S. Harding](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robin S. Harding
Nessuna posizione attualmente
Profilo
Robin S.
Harding served as the Chief Executive Officer of Citizens United for Research in Epilepsy and as the Chief Operating Officer & EVP-Development of JDRF International.
Harding obtained an undergraduate degree from the University of Illinois.
Precedenti posizioni note di Robin S. Harding
Società | Posizione | Fine |
---|---|---|
Citizens United for Research in Epilepsy
![]() Citizens United for Research in Epilepsy Miscellaneous Commercial ServicesCommercial Services Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean. | Amministratore Delegato | - |
JDRF International
![]() JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Direttore operativo | - |
Formazione di Robin S. Harding
University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
JDRF International
![]() JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
Citizens United for Research in Epilepsy
![]() Citizens United for Research in Epilepsy Miscellaneous Commercial ServicesCommercial Services Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean. | Commercial Services |
- Borsa valori
- Insiders
- Robin S. Harding